Nanomaterials,
Год журнала:
2025,
Номер
15(10), С. 704 - 704
Опубликована: Май 8, 2025
Intrinsically
disordered
proteins
(IDPs),
such
as
tau,
beta-amyloid
(Aβ),
and
alpha-synuclein
(αSyn),
are
prone
to
misfolding,
resulting
in
pathological
aggregation
propagation
that
drive
neurodegenerative
diseases,
including
Alzheimer’s
disease
(AD),
frontotemporal
dementia
(FTD),
Parkinson’s
(PD).
Misfolded
IDPs
aggregate
into
oligomers
fibrils,
exacerbating
progression
by
disrupting
cellular
functions
the
central
nervous
system,
triggering
neuroinflammation
neurodegeneration.
Furthermore,
aggregated
exhibit
prion-like
behavior,
acting
seeds
released
extracellular
space,
taken
up
neighboring
cells,
have
a
propagating
pathology
across
different
regions
of
brain.
Conventional
inhibitors,
small
molecules,
peptides,
antibodies,
face
challenges
stability
blood–brain
barrier
penetration,
limiting
their
efficacy.
In
recent
years,
nanotechnology-based
strategies,
multifunctional
nanoplatforms
or
nanoparticles,
emerged
promising
tools
address
these
challenges.
These
leverage
tailored
designs
prevent
remodel
reduce
associated
neurotoxicity.
This
review
discusses
advances
designed
target
Aβ,
αSyn
aggregation,
with
focus
on
roles
reducing
We
examine
critical
aspects
nanoplatform
design,
choice
material
backbone
targeting
moieties,
which
influence
interactions
IDPs.
also
highlight
key
mechanisms
interaction
between
inhibit
redirect
cascade
towards
nontoxic,
off-pathway
species,
disrupt
fibrillar
structures
soluble
forms.
further
outline
future
directions
for
enhancing
IDP
clearance,
achieving
spatiotemporal
control,
improving
cell-specific
targeting.
nanomedicine
strategies
offer
compelling
paths
forward
developing
more
effective
targeted
therapies
diseases.
Ageing Research Reviews,
Год журнала:
2024,
Номер
99, С. 102357 - 102357
Опубликована: Июнь 1, 2024
Neurodegenerative
disorders
(NDs)
are
expected
to
pose
a
significant
challenge
for
both
medicine
and
public
health
in
the
upcoming
years
due
global
demographic
changes.
NDs
mainly
represented
by
degeneration/loss
of
neurons,
which
is
primarily
accountable
severe
mental
illness.
This
neuronal
degeneration
leads
many
neuropsychiatric
problems
permanent
disability
an
individual.
Moreover,
tight
junction
brain,
blood-brain
barrier
(BBB)has
protective
feature,
functioning
as
biological
that
can
prevent
medicines,
toxins,
foreign
substances
from
entering
brain.
However,
delivering
any
medicinal
agent
brain
(i.e.,
Multiple
sclerosis,
Alzheimer's,
Parkinson's,
etc.)
enormously
challenging.
There
approved
therapies
address
NDs,
but
most
them
only
help
treat
associated
manifestations.
The
available
have
failed
control
progression
certain
factors,
i.e.,
BBB
drug-associated
undesirable
effects.
extremely
complex
pathology,
with
pathogenic
mechanisms
involved
initiation
progression;
thereby,
limited
survival
rate
has
been
observed
ND
patients.
Hence,
understanding
exact
mechanism
behind
crucial
developing
alternative
approaches
improving
patients'
rates.
Thus,
present
review
sheds
light
on
different
cellular
novel
therapeutic
their
clinical
relevance,
will
assist
researchers
alternate
strategies
limitations
conventional
therapies.
current
work
offers
scope
into
near
future
improve
approach
NDs.
Pharmaceutics,
Год журнала:
2023,
Номер
15(9), С. 2361 - 2361
Опубликована: Сен. 21, 2023
Nanoformulations
have
become
increasingly
useful
as
drug
delivery
technologies
in
recent
decades.
As
therapeutics,
oral
administration
is
the
most
common
method,
although
it
not
always
effective
route
because
of
challenges
with
swallowing,
gastrointestinal
discomfort,
low
solubility,
and
poor
absorption.
One
significant
barriers
that
medications
must
overcome
to
exert
a
therapeutic
effect
impact
first
hepatic
transit.
Studies
shown
controlled-release
systems
using
nanoparticles
composed
biodegradable
natural
polymers
significantly
improve
administration,
which
why
these
materials
attracted
attention.
Chitosan
possesses
wide
variety
properties
functions
pharmaceutical
well
healthcare
industries.
Drug
encapsulation
transport
within
body
are
two
its
important
features.
Moreover,
chitosan
can
enhance
efficacy
by
facilitating
interaction
target
cells.
Based
on
physicochemical
properties,
potentially
be
synthesized
into
nanoparticles,
this
review
summarizes
advances
applications
orally
delivered
nanoparticle
interventions.
Medicine in Novel Technology and Devices,
Год журнала:
2023,
Номер
17, С. 100217 - 100217
Опубликована: Фев. 25, 2023
Nanotechnology
is
a
rapidly
expanding
discipline,
and
solid
lipid
nanoparticles
(SLN)
are
at
the
forefront
of
this
development.
They
offer
various
possible
clinical
pharmaceutical
research
applications
numerous
other
fields.
A
quantitative
review
technique
called
bibliometric
analysis
uses
statistics,
data
mining,
mathematics
to
find
emerging
trends
in
particular
academic
topic.
It
currently
more
widely
utilized
employed
many
subjects.
As
result,
current
study
looked
through
Scopus-indexed
documents
on
SLNs
from
2012
2022
assess
growth
expansion
body
knowledge
predict
its
course
future.
The
VOSviewer
package
Scopus
Analytics
were
used
conduct
analysis.
offers
two
distinct
viewing
modes:
network
overlay
visualization.
total
3768
journal
articles
(n
=
3709)
conference
papers
59)
extracted.
number
published
by
12,367
authors
was
steadily
increasing
annually.
Gene
therapy,
development
detection
methods,
bioavailability,
controlled
release
have
been
important
Souto,
E.B.,
University
Porto
Portugal,
considered
most
prolific
frequently
cited
scholar.
Punjab
(India)
top-publishing
institution.
India
leading
country
publications
collaborations.
International
Journal
Pharmaceutics
top
source.
results
keep
pace
with
global
scientific
efforts
nanotechnology
successfully
integrate
them
into
industry.
ACS Applied Bio Materials,
Год журнала:
2024,
Номер
7(3), С. 1336 - 1361
Опубликована: Фев. 27, 2024
Over
the
past
decade,
nanotechnology
has
seen
extensive
integration
into
biomedical
applications,
playing
a
crucial
role
in
biodetection,
drug
delivery,
and
diagnostic
imaging.
This
is
especially
important
reproductive
health
care,
which
become
an
emerging
significant
area
of
research.
Global
concerns
have
intensified
around
disorders
such
as
infertility,
endometriosis,
ectopic
pregnancy,
erectile
dysfunction,
benign
prostate
hyperplasia,
sexually
transmitted
infections,
cancers.
Nanotechnology
presents
promising
solutions
to
address
these
by
introducing
innovative
tools
techniques,
facilitating
early
detection,
targeted
improved
imaging
capabilities.
Through
utilization
nanoscale
materials
devices,
researchers
can
craft
treatments
that
are
not
only
more
precise
but
also
effective,
significantly
enhancing
outcomes
healthcare.
Looking
forward,
future
medicine
holds
immense
potential
for
reshaping
diagnostics,
personalized
therapies,
fertility
preservation.
The
nanotechnology-driven
delivery
systems
anticipated
elevate
treatment
effectiveness,
minimize
side
effects,
offer
patients
therapies
efficient.
review
aims
delve
various
types,
properties,
preparation
techniques
nanocarriers
specifically
designed
context
disorders,
shedding
light
on
current
landscape
directions
this
dynamic
field.
Accounts of Chemical Research,
Год журнала:
2024,
Номер
57(11), С. 1633 - 1647
Опубликована: Май 16, 2024
ConspectusThe
identification
of
neural
networks
for
large
areas
and
the
regulation
neuronal
activity
at
single-neuron
scale
have
garnered
considerable
attention
in
neuroscience.
In
addition,
detecting
biochemical
molecules
electrically,
optically,
chemically
controlling
functions
are
key
research
issues.
However,
conventional
rigid
bulky
bioelectronics
face
challenges
applications,
including
mechanical
mismatch,
unsatisfactory
signal-to-noise
ratio,
poor
integration
multifunctional
components,
thereby
degrading
sensing
modulation
performance,
long-term
stability
biocompatibility,
diagnosis
therapy
efficacy.
Implantable
been
developed
to
be
mechanically
compatible
with
brain
environment
by
adopting
advanced
geometric
designs
utilizing
intrinsically
stretchable
materials,
but
such
advances
not
able
address
all
aforementioned
challenges.Recently,
exploration
nanomaterial
synthesis
nanoscale
fabrication
strategies
has
facilitated
design
unconventional
soft
properties
similar
those
tissues
submicrometer-scale
resolution
comparable
typical
neuron
sizes.
The
introduction
nanotechnology
provided
improved
spatial
resolution,
selectivity,
single
targeting,
even
multifunctionality.
As
a
result,
this
state-of-the-art
integrated
two
main
types,
i.e.,
synthesized
nanomaterials
structures.
functional
can
assembled
compose
bioelectronics,
allowing
easy
customization
their
functionality
meet
specific
requirements.
unique
structures
implemented
could
maximize
performance
terms
stimulation.
Such
nanobioelectronics
demonstrated
applicability
recording
over
long
period
intracellular
level
incorporation
multiple
functions,
as
electrical,
optical,
chemical
stimulation
functions.In
Account,
we
will
discuss
technical
pathways
implementing
nanostructures
application
neuroengineering.
We
traced
historical
development
from
deformable
devices
conform
neuroengineering
Recent
approaches
that
introduced
into
enhanced
spatiotemporal
endowed
various
device
functions.
These
nanobioelectronic
technologies
discussed
categories:
describe
nanomaterial-integrated
exhibiting
functionalities
modalities
depending
on
nanomaterials.
Meanwhile,
explained
superior
administration
methods.
also
exemplified
applications
across
modalities,
showcasing
clinical
treatment
neurological
diseases,
tumors,
epilepsy,
Parkinson's
disease.
Finally,
direction
next-generation
technologies.
Nanomaterials,
Год журнала:
2023,
Номер
13(23), С. 3004 - 3004
Опубликована: Ноя. 23, 2023
The
lack
of
effective
treatments
for
neurodegenerative
diseases
(NDs)
is
an
important
current
concern.
Lipid
nanoparticles
can
deliver
innovative
combinations
active
molecules
to
target
the
various
mechanisms
neurodegeneration.
A
significant
challenge
in
delivering
drugs
brain
ND
treatment
associated
with
blood–brain
barrier,
which
limits
effectiveness
conventional
drug
administration.
Current
strategies
utilizing
lipid
and
cell-penetrating
peptides,
characterized
by
uptake
mechanisms,
have
potential
extend
residence
time
bioavailability
encapsulated
drugs.
Additionally,
bioactive
neurotropic
or
neuroprotective
properties
be
delivered
potentially
mediate
targeting
pathways,
e.g.,
neurotrophin
deficiency,
impaired
metabolism,
mitochondrial
dysfunction,
endoplasmic
reticulum
stress,
accumulation
misfolded
proteins
peptide
fragments,
toxic
protein
aggregates,
oxidative
stress
damage,
neuroinflammation.
This
review
discusses
recent
advancements
CPPs
view
integration
these
two
approaches
into
nanomedicine
development
dual-targeted
nanoparticulate
systems
delivery
disorders.
Molecular Pharmaceutics,
Год журнала:
2023,
Номер
20(10), С. 4922 - 4941
Опубликована: Сен. 12, 2023
Cardiovascular
diseases
(CVDs)
refer
to
a
collection
of
conditions
characterized
by
abnormalities
in
the
cardiovascular
system.
They
are
global
problem
and
one
leading
causes
mortality
disability.
Nanotheranostics
implies
combination
diagnostic
therapeutic
capabilities
inside
single
nanoscale
platform
that
has
allowed
for
significant
advancement
diagnosis
therapy.
These
advancements
being
developed
improve
imaging
capabilities,
introduce
personalized
therapies,
boost
disease
patient
treatment
outcomes.
Significant
progress
been
achieved
integration
within
nanocarriers.
In
case
disease,
nanoparticles
provide
targeted
delivery
therapeutics,
genetic
material,
photothermal,
agents.
Directing
monitoring
movement
these
may
be
done
with
pinpoint
accuracy
using
modalities
such
as
magnetic
resonance
(CMR),
computed
tomography
(CT),
positron
emission
(PET),
photoacoustic/ultrasound,
fluorescence
imaging.
Recently,
there
an
increasing
demand
noninvasive
multimodal
nanotheranostic
platforms.
platforms,
various
technologies
optical
integrated
into
nanoparticle.
This
helps
acquiring
more
accurate
descriptions
provides
clues
diagnosis.
Advances
surface
functionalization
methods
have
strengthened
potential
application
nanotheranostics
this
Review,
we
covered
impact
nanomedicine
on
CVDs.
Additionally,
discussed
recently
CVDs
Moreover,
CMR,
CT,
PET,
ultrasound,
photoacoustic
discussed.
We
limited
our
discussion
nanomaterials
based
clinical
trials
their
patents.
Biosensors and Bioelectronics,
Год журнала:
2024,
Номер
260, С. 116446 - 116446
Опубликована: Май 28, 2024
Understanding
brain
function
is
essential
for
advancing
our
comprehension
of
human
cognition,
behavior,
and
neurological
disorders.
Magnetic
resonance
imaging
(MRI)
stands
out
as
a
powerful
tool
exploring
function,
providing
detailed
insights
into
its
structure
physiology.
Combining
MRI
technology
with
electrophysiological
recording
system
can
enhance
the
functionality
through
synergistic
effects.
However,
integration
neural
implants
presents
challenges
because
strong
electromagnetic
(EM)
energy
during
scans.
Therefore,
MRI-compatible
should
facilitate
investigation
activities
functions
in
real-time
high
resolution,
without
compromising
patient
safety
quality.
Here,
we
introduce
fully
monolayer
pristine
open-mesh
PEDOT:PSS
interface.
This
approach
addresses
encountered
while
using
traditional
metal-based
electrodes
environment
such
induced
heat
or
artifacts.
has
diamagnetic
property
lower
electrical
conductivity
negative
magnetic
susceptibility
similar
to
tissues.
Furthermore,
by
adopting
optimized
structure,
currents
generated
EM
are
significantly
diminished,
leading
compatibility.
Through
simulations
experiments,
PEDOT:PSS-based
showed
improved
performance
reducing
generation
eliminating
artifacts
an
environment.
The
capability
was
also
validated
measuring
local
field
potential
(LFP)
from
somatosensory
cortex
vivo
experiment.
development
maximized
compatibility
indicates
possibility
tools
future
diagnostics.
La
nanomedicina
es
el
nombre
que
se
asigna
a
las
tecnologías
nanométricas
aplicadas
al
cuidado
de
la
salud,
cuales
han
permitido
desarrollo
estrategias
innovadoras
para
tratamiento
y
diagnóstico
diversas
enfermedades,
incluidas
aquellas
afectan
sistema
nervioso
central.
En
particular,
debido
ventajas
conferidas
por
sus
características
intrínsecas,
nanomedicinas
explorado
como
una
posible
alternativa
terapéutica
permita
optimizar
control
crisis
epilépticas
epilepsia
través
diversos
enfoques,
pueden
incluir
mejorar
farmacocinética
los
fármacos
anticrisis,
reducir
efectos
adversos,
aumentar
su
eficacia
y,
en
algunos
casos,
superar
farmacorresistencia.
Estas
posicionan
herramienta
muy
atractiva
ayude
desafíos
imposibilitado
óptimo
ciertos
casos
particulares,
Esta
revisión
aborda
aspectos
generales
sobre
epilepsia,
proporcionando
un
contexto
fisiopatología
asociados
con
tratamientos
esta
enfermedad.
Además,
recopilan
evidencias
evaluado
uso
potencial
diferentes
modelos
animales
agudas,
así
responsiva
refractaria
tratamiento,
desde
enfoque
ciencia
básica.
Estos
estudios
proporcionan
evidencia
fundamental,
ámbito
medicina
traslacional,
sienta
bases
futuras
aplicaciones
trasladarse
eventualmente
práctica
clínica
trastornos
epilépticos.